No link between COVID vaccines and infection during pregnancy and developmental delays in toddlers
Women who got COVID-19 or were vaccinated during pregnancy do not have a higher risk of having children with developmental problems, according to a major new study from Scotland.
Previous research in Switzerland and the United States offered some reassurance, but the new study, published in The Lancet Child and Adolescent Health journal on Wednesday, is the largest analysis to date to confirm the safety of the vaccine for pregnant women and their babies.
The study included nearly 25,000 babies born in Scotland in 2020 and 2021.
Health workers visited the families' homes for routine checks when the babies were 13 to 15 months old, monitoring any concerns with speech, language skills, thinking, emotional development, and physical movement.
Researchers from the University of Edinburgh then tracked their mothers' health histories – and found no link between COVID-19 infection or vaccination during pregnancy and child development issues.
The findings held up regardless of which trimester the mothers were vaccinated or infected.
The researchers said the results should bolster parents' confidence in the safety of the jabs, especially given that early COVID-19 vaccine trials excluded pregnant women.
'Vaccination safety is something that has been called into question quite a lot recently,' Bonnie Auyeung, the study's senior author and a reader in child health at the University of Edinburgh, told Euronews Health.
'Hopefully these early findings will support parents and their decisions around whether or not to take the vaccine, and for those who do take it, it does appear that it is safe for the developing child'.
Developmental issues more evident in older children
According to the European Medicines Agency (EMA), which regulates drugs and vaccines in the European Union, COVID-19 vaccines do not raise the risk of pregnancy complications, miscarriage, premature birth, or health issues for babies.
Notably, women who get COVID-19 during pregnancy are more likely to fall seriously ill, especially in the second and third trimesters, the agency says.
The study authors noted that developmental concerns aren't always noticed until children are older.
They said they plan to follow the same families in the coming years to track whether a link emerges. However, for now, the findings should help bolster guidance from doctors and other medical professionals that the vaccine is safe for pregnant women and their babies.
'Clinical guidance is still quite mixed,' Auyeung said, but 'it does appear that vaccination during pregnancy doesn't actually lead to any developmental problems'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
France 24
2 hours ago
- France 24
Germany's BioNTech to buy CureVac to boost cancer research
BioNTech, which developed the first coronavirus vaccine to be approved in the West along with US pharmaceutical giant Pfizer, said the acquisition would "bring together complementary capabilities and leverage technologies". Both biotech companies have been working for years in the area of mRNA vaccines and treatments, which provoke an immune response by delivering genetic molecules containing the code for key parts of a pathogen into human cells. While the technology became well known in relation to some Covid-19 vaccines, it is also being used in other areas, and scientists believe it could be a game-changer against many diseases. BioNTech said the acquisition of CureVac would help boost its work in the field of mRNA-based cancer immunotherapy -- treatment that uses the body's own immune system to fight diseases. "This transaction is another building block in BioNTech's oncology strategy and an investment in the future of cancer medicine," said BioNTech CEO Ugur Sahin. It was aimed at "establishing new standards of care for various types of cancer in the coming years," he said. Alexander Zehnder, CEO of CureVac, said the purchase would bring scientific expertise, technology and manufacturing know-how "in the mRNA field under one roof". BioNTech's all-stock acquisition has been unanimously approved by the companies' management and supervisory boards, and is expected to close in 2025, subject to certain conditions including regulatory approvals. Both companies are listed on the Nasdaq Composite Index. They had both sought to develop Covid-19 vaccines during the pandemic, with Mainz-based BioNTech's Comirnaty jab winning approval and going on to become one of the most widely used shots against the virus around the world. But Tuebingen-based CureVac, founded 25 years ago by mRNA pioneer Ingmar Hoerr, abandoned its efforts in late 2021 after disappointing trial results. In 2022, CureVac sued BioNTech for patent infringement over its rival's use of the technology.
LeMonde
a day ago
- LeMonde
In bed and on the job: How to stay productive while lying down
With the democratization of remote work, our potential workspaces have expanded to include an unexpected area from which it is now accepted that one can move projects forward like Sisyphus in pajamas: the bed. Indeed, when working from home, it is tempting to abandon the uncomfortable sitting posture and, at some point, relocate to that soft and rectangular haven that seems to beckon us. Let anyone who has never attended a remote meeting from their mattress throw the first memory foam pillow at me! Although difficult to quantify, this trend seems to have taken root. A study conducted in 2020 by Tuck Sleep, which researches sleep for commercial purposes, showed that the Covid-19 pandemic had the side effect of increasing the amount of work done from bed. Among the 1,000 Americans surveyed, 8.8% spent between 24 to 40 hours per week in a paradoxical state of being both supine and productive. Even though it evokes a sense of hedonism, calling to mind the tutelary figures of Alexandre le Bienheureux (the indolent hero of the 1968 French cult film Very Happy Alexander) or Playboy founder Hugh Hefner – or even Winston Churchill, who also worked from his bed – this posture is sometimes a necessity, dictated by the lack of a proper desk in small apartments. Despite its promises of an improbable mix between work and leisure, it often proves uncomfortable in practice. As a passive variable in a society where information flows rapidly, you may find yourself at risk for back pain or a stiff neck caused by an excessively static posture. All the micro-efforts you make during a day at the office without even realizing it (walking to the printer, the cafeteria or grabbing a coffee) vanish if you spend the majority of your working life lying down. This extreme sedentarity, which takes you from bed to bed, is accompanied by increased morbidity, exacerbating cardiovascular, metabolic and musculoskeletal issues. Hybrid spaces Despite its risks, this temptation has become a new market, as evidenced by the fact that, on Amazon, one can purchase an intriguing cushion-desk on which to place a laptop and a latte, working while feeling like you're having breakfast at a hotel. Ikea has even launched a section on its website titled "How to work comfortably (and productively) from bed," where the hybridization of spaces dominates, neither truly restful places nor entirely credible work zones. Hence the recurring joke on TikTok, under the hashtag #WorkFromBed, in which an employee emerging from under the covers declares vindictively, "Oh, I'm at the office now!" In a Reddit conversation dedicated to the theme of working from bed, it is clear that the reasons motivating this practice are very eclectic: pain (such as menstrual cramps), fatigue, the comfort provided by blankets, depression, the demand to work from wherever one wishes, the creative necessity to let one's mind wander... Nevertheless, all of this requires certain arrangements to ensure that the realms of work and rest do not become completely indistinguishable. "I just make sure to have a transition between work and sleep: put away the laptop, go to other spaces to do something else before going to bed," shares BostonBluestocking. Is the horizontal worker not, ultimately, the most perfected product of a deverticalized working world, at last?
France 24
2 days ago
- France 24
US restores some medical research grants, says top Trump official
Jay Bhattacharya, director of the National Institutes of Health (NIH), made the remarks during a Senate committee hearing examining both recent cuts to his agency and deeper reductions proposed by the White House in next year's budget. Bhattachartya said he had created an appeals process for scientists and laboratories whose research was impacted, and that the NIH had already "reversed many" of the cuts. "I didn't take this job to terminate grants," said the physician and health economist who left a professorship at Stanford University to join the Trump administration. "I took this job to make sure that we do the research that advances the health needs of the American people." The hearing came a day after more than 60 NIH employees sent an open letter to Bhattacharya condemning policies they said undermined the agency's mission and the health of Americans. They dubbed it the "Bethesda Declaration" -- a nod both to the NIH's suburban Washington headquarters and to Bhattacharya's role as a prominent signatory of the 2020 "Great Barrington Declaration," which opposed Covid lockdowns. Since Trump's January 20 inauguration, the NIH has terminated 2,100 research grants totaling around $9.5 billion and $2.6 billion in contracts, according to an independent database called Grant Watch. Affected projects include studies on gender, the health effects of global warming, Alzheimer's disease, and cancer.
